Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Promising effects and safety profile found for PT-141 in erectile dysfunction

March 5, 2004

Uroxatral launched to primary-care physicians

March 5, 2004

Good safety and pharmacokinetic profile found for a buccal testosterone formulation

March 5, 2004

Endpoint met in phase IIa study of DMI-7958

March 4, 2004

Solifenacin reported both safe and effective in overactive bladder

March 4, 2004

Duloxetine improves voiding and quality of life of women with stress urinary incontinence

March 3, 2004

Acetylcysteine improves cardiovascular morbidity in renal failure

March 2, 2004

Sosei and Arachnova in licensing agreement in stress urinary incontinence

March 1, 2004

Uroflux completes phase II trial for BPH

Feb. 27, 2004

European label change for Cialis to include 36-hour efficacy claim

Feb. 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...